dna patenting gene

Exploring the Patentability of Human DNA: A Comprehensive Analysis of Legal Perspectives and Scientific Implications


The realm of biotechnology has been a hotbed of innovation and discovery, with DNA research leading the charge. As we delve deeper into the mysteries of the human genome, the question of DNA patenting has emerged as a contentious issue. This article aims to shed light on the complex landscape of DNA patenting, its legal implications, and its potential impact on scientific research.

Brief Overview of DNA Patenting

DNA patenting refers to the legal process of claiming ownership over a specific sequence of DNA, a gene, or a part of a gene. This practice has its roots in the broader field of biotechnology patenting, where inventions related to living organisms and their processes can be protected under patent law. DNA patenting has become a focal point of discussion due to its potential implications on scientific research, healthcare, and ethics.

Importance of the Topic

The patentability of human DNA is not just a legal issue, but a matter that intersects with science, ethics, and public policy. It has the potential to shape the future of genetic research, personalized medicine, and even our understanding of life itself. Therefore, it is crucial to explore this topic from multiple perspectives to ensure a balanced and informed discourse.

Understanding DNA and its Importance

What is DNA?

DNA, or deoxyribonucleic acid, is the molecular blueprint of life. It carries the genetic instructions used in the growth, development, functioning, and reproduction of all known organisms and many viruses. DNA molecules are double-stranded helices, each composed of nucleotide units containing a sugar, a phosphate, and one of four nitrogenous bases.

Role of DNA in Human Life

In humans, DNA plays a pivotal role in determining our physical characteristics, susceptibility to certain diseases, and even aspects of our behavior. It is the genetic material that parents pass on to their offspring, ensuring the continuity of life from one generation to the next.

Brief History of DNA Research

The discovery of DNA dates back to the 19th century, but it was not until the mid-20th century that scientists James Watson and Francis Crick unveiled its double helix structure. Since then, advancements in DNA research have been monumental, culminating in the completion of the Human Genome Project in 2003, which mapped the entire human genome.

The Concept of Patenting in Biotechnology

Definition of Patenting

A patent is a legal right granted by a government to an inventor, giving them exclusive rights to their invention for a limited period. This allows inventors to prevent others from making, using, or selling their invention without permission.

Importance of Patenting in Biotechnology

Patenting is particularly important in biotechnology, a field characterized by high research and development costs and long lead times before a product can be commercialized. Patents provide a temporary monopoly that allows biotech companies to recoup their investment and fund future research.

Examples of Patented Biotechnological Inventions

Biotechnological inventions that have been patented range from genetically modified organisms (GMOs) to methods for producing biopharmaceuticals. One of the most famous examples is the Oncomouse, a genetically modified mouse used in cancer research, which was patented by Harvard University in the 1980s.

The Controversy Surrounding DNA Patenting

Arguments for DNA Patenting

Proponents of DNA patenting argue that it incentivizes innovation by providing financial rewards for research and development. They contend that without the promise of patent protection, companies may be less willing to invest in the costly and time-consuming process of genetic research.

Arguments against DNA Patenting

Critics, on the other hand, argue that DNA is a product of nature and should not be subject to ownership. They fear that DNA patents could hinder research by restricting access to genetic material and argue that it is ethically problematic to commodify the building blocks of life.

Ethical Considerations

The ethical debate surrounding DNA patenting is complex. It touches on issues of fairness, the commodification of life, and the potential for exploitation. For instance, should companies be able to profit from genetic resources that are part of our common heritage? And what are the implications for patients who need genetic testing or therapies that are protected by patents?

The Supreme Court’s Ruling on DNA Patenting

Overview of the Supreme Court’s Decision

In 2013, the Supreme Court of the United States made a landmark ruling in the case of Association for Molecular Pathology v. Myriad Genetics, Inc. The court ruled that naturally occurring DNA sequences cannot be patented because they are products of nature. However, the court held that cDNA, a form of DNA created in the lab, is patentable because it does not occur naturally.

Implications of the Ruling

The Supreme Court’s decision has had significant implications for biotechnology companies, researchers, and patients. On one hand, it has opened up previously patented genetic sequences for research and clinical testing. On the other hand, it has raised questions about the patentability of other biotechnological inventions that involve natural products.

Analysis of the Court’s Reasoning

The court’s reasoning hinged on the distinction between natural and synthetic products. While acknowledging the important role of Myriad Genetics in isolating the BRCA1 and BRCA2 genes, which are associated with an increased risk of breast and ovarian cancer, the court maintained that merely isolating a gene does not make it a human invention.

Complementary DNA (cDNA) and its Patentability

Understanding cDNA

Complementary DNA (cDNA) is a form of DNA that is synthesized from a messenger RNA (mRNA) template in a process catalyzed by the enzyme reverse transcriptase. cDNA is often used in gene cloning or as a template for PCR, a technique used to amplify DNA.

How cDNA Differs from Natural DNA

Unlike natural DNA, cDNA does not contain introns, non-coding regions of DNA that are present in the original DNA sequence but are removed during the process of transcription and translation in protein synthesis. This is one of the key reasons why cDNA, unlike natural DNA, was deemed patentable by the Supreme Court.

Why cDNA is Eligible for Patenting

The court ruled that cDNA is patentable because it is not naturally occurring. The process of creating cDNA involves human intervention to convert mRNA into a DNA sequence. Therefore, cDNA does not fall under the “products of nature” exception to patentability.

Impact of DNA Patenting on Scientific Research

Potential Benefits of DNA Patenting

DNA patenting can incentivize innovation by providing a financial reward for new discoveries. This can stimulate investment in genetic research and lead to the development of new diagnostic tests, therapies, and biotechnological products.

Potential Drawbacks of DNA Patenting

Conversely, DNA patenting can also create barriers to research. If a company holds a patent on a specific gene, other researchers must obtain permission to study that gene or risk infringing the patent. This can slow down the pace of research and limit the sharing of knowledge.

Case Studies of DNA Patenting Impact on Research

One notable example of the impact of DNA patenting on research is the case of Myriad Genetics. Before the Supreme Court’s ruling, Myriad held patents on the BRCA1 and BRCA2 genes and was the only company in the U.S. that could perform testing for mutations on these genes. After the ruling, other laboratories were able to offer this testing, leading to increased competition and lower prices.

International Perspectives on DNA Patenting

European Union’s Stance on DNA Patenting

In the European Union, the Biotech Directive governs the patentability of biotechnological inventions. According to the directive, biological material that is isolated from its natural environment or produced by means of a technical process can be patented, even if it previously occurred in nature. This includes gene sequences, as long as their industrial application is disclosed in the patent application.

DNA Patenting in Asia: A Comparative Analysis

In Asia, the approach to DNA patenting varies by country. Japan, for instance, allows the patenting of isolated DNA sequences, while India prohibits the patenting of naturally occurring DNA, even if it is isolated. China, on the other hand, allows the patenting of DNA sequences as long as they are part of a larger invention and not claimed in isolation.

DNA Patenting in Other Parts of the World

In other parts of the world, the approach to DNA patenting is equally diverse. In Australia, for example, the High Court has ruled that isolated DNA cannot be patented, aligning with the U.S. Supreme Court’s decision. Meanwhile, in Canada, the patentability of DNA remains a grey area, with no definitive rulings from the courts.

Future of DNA Patenting

Predicted Trends in DNA Patenting

As our understanding of the human genome continues to evolve, so too will the landscape of DNA patenting. One trend to watch is the shift towards patenting methods of using genetic information, rather than the genetic information itself. This reflects a broader trend in biotechnology patenting towards process-based patents.

Potential Changes in Legislation

Legislation around DNA patenting may also change in response to advances in genetic technology and shifting public sentiment. For instance, lawmakers may choose to clarify the scope of the “products of nature” exception or introduce new legislation to address emerging issues in genetic technology, such as gene editing and synthetic biology.

Role of Technology in Shaping the Future of DNA Patenting

Technological advancements will undoubtedly play a key role in shaping the future of DNA patenting. New techniques for sequencing, analyzing, and manipulating DNA could give rise to novel inventions that challenge our current understanding of what constitutes a patentable invention.


The patentability of human DNA is a complex issue that lies at the intersection of law, science, and ethics. As we continue to unravel the mysteries of the human genome, it is crucial that we navigate this legal and ethical terrain with care, balancing the need to incentivize innovation with the imperative to promote scientific research and respect the dignity of human life.

The Supreme Court’s ruling on DNA patenting has provided some clarity, but many questions remain. As we look to the future, it is clear that the dialogue around DNA patenting will continue to evolve, shaped by advances in technology, shifts in public sentiment, and ongoing legal and ethical debates.

Frequently Asked Questions

What is DNA patenting?

DNA patenting refers to the legal process of claiming ownership over a specific sequence of DNA, a gene, or a part of a gene.

Why is DNA patenting controversial?

DNA patenting is controversial because it raises questions about the commodification of life, the potential for exploitation, and the impact on scientific research and healthcare.

What was the Supreme Court’s ruling on DNA patenting?

The Supreme Court ruled that naturally occurring DNA sequences cannot be patented because they are products of nature. However, cDNA, a form of DNA created in the lab, is patentable.

What is cDNA and why is it patentable?

cDNA is a form of DNA that is synthesized from a messenger RNA (mRNA) template. It is patentable because it does not occur naturally and its creation involves human intervention.

How does DNA patenting impact scientific research?

DNA patenting can both incentivize and hinder scientific research. On one hand, it can stimulate innovation by providing a financial reward for new discoveries. On the other hand, it can create barriers to research by restricting access to patented genetic material.

How do international perspectives on DNA patenting differ?

International perspectives on DNA patenting vary widely. Some jurisdictions, like the European Union and Japan, allow the patenting of isolated DNA sequences. Others, like India and Australia, prohibit the patenting of naturally occurring DNA, even if it is isolated.


  • Supreme Court of the United States. (2013). Association for Molecular Pathology v. Myriad Genetics, Inc.
  • National Human Genome Research Institute. (2021). Genomic Law Report.
  • World Intellectual Property Organization. (2021). Patenting in Biotechnology.
  • European Patent Office. (2021). Biotechnological Inventions.
  • World Health Organization. (2021). Genomics and World Health Report.


| Modified:



Image of Michael Thompson
Michael Thompson

Michael Thompson is a passionate science historian and blogger, specializing in the captivating world of evolutionary theory. With a Ph.D. in history of science from the University of Chicago, he uncovers the rich tapestry of the past, revealing how scientific ideas have shaped our understanding of the world. When he’s not writing, Michael can be found birdwatching, hiking, and exploring the great outdoors. Join him on a journey through the annals of scientific history and the intricacies of evolutionary biology right here on WasDarwinRight.com.